ALTSHULER DAVID 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 27, 2024
Insider Transaction Report
Form 4
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2024-02-23$431.79/sh−3,970$1,714,206→ 30,052 total - Sale
Common Stock
2024-02-26$425.70/sh−4,239$1,804,542→ 25,813 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 5/10/2023.